• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.

作者信息

Terdiman Jonathan P, Gruss Claudia B, Heidelbaugh Joel J, Sultan Shahnaz, Falck-Ytter Yngve T

机构信息

Division of Gastroenterology, University of California, San Francisco School of Medicine, San Francisco, California.

出版信息

Gastroenterology. 2013 Dec;145(6):1459-63. doi: 10.1053/j.gastro.2013.10.047.

DOI:10.1053/j.gastro.2013.10.047
PMID:24267474
Abstract
摘要

相似文献

1
American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.美国胃肠病学会关于硫唑嘌呤、甲氨蝶呤和抗TNF-α生物药物用于诱导和维持炎症性克罗恩病缓解的指南。
Gastroenterology. 2013 Dec;145(6):1459-63. doi: 10.1053/j.gastro.2013.10.047.
2
American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.美国胃肠病学会研究所关于硫唑嘌呤、甲氨蝶呤和抗TNF-α生物药物用于诱导和维持炎症性克罗恩病缓解的技术审查。
Gastroenterology. 2013 Dec;145(6):1464-78.e1-5. doi: 10.1053/j.gastro.2013.10.046.
3
Therapeutic role of methotrexate in pediatric Crohn's disease.甲氨蝶呤在小儿克罗恩病中的治疗作用。
Bosn J Basic Med Sci. 2018 Aug 1;18(3):211-216. doi: 10.17305/bjbms.2018.2792.
4
Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective.硫嘌呤类药物与炎症性肠病：当前证据及历史视角
World J Gastroenterol. 2016 Dec 14;22(46):10103-10117. doi: 10.3748/wjg.v22.i46.10103.
5
Methotrexate for Crohn's disease.用于克罗恩病的甲氨蝶呤
N Engl J Med. 1995 Aug 31;333(9):600-1. doi: 10.1056/NEJM199508313330917.
6
T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.向 FDA AERS 报告的使用肿瘤坏死因子-α（TNF-α）抑制剂的 T 细胞非霍奇金淋巴瘤：REFURBISH 研究结果。
Am J Gastroenterol. 2013 Jan;108(1):99-105. doi: 10.1038/ajg.2012.334. Epub 2012 Oct 2.
7
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.加拿大胃肠病学会腔克罗恩病管理临床实践指南。
Clin Gastroenterol Hepatol. 2019 Aug;17(9):1680-1713. doi: 10.1016/j.cgh.2019.02.043. Epub 2019 Mar 7.
8
The debated role for thiopurines in Crohn's disease.硫唑嘌呤在克罗恩病中的作用存在争议。
J Crohns Colitis. 2014 Feb;8(2):172-4. doi: 10.1016/j.crohns.2013.11.026. Epub 2013 Dec 15.
9
Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.儿童炎症性肠病的免疫抑制治疗：北美儿科胃肠病学与营养学会的一项调查结果。儿科炎症性肠病协作研究论坛免疫抑制应用小组委员会。
Am J Gastroenterol. 1993 Jan;88(1):44-8.
10
Certolizumab pegol for the management of Crohn's disease in adults.聚乙二醇化赛妥珠单抗用于成人克罗恩病的治疗
Clin Ther. 2009 Jun;31(6):1158-76. doi: 10.1016/j.clinthera.2009.06.015.

引用本文的文献

1
Translocator protein facilitates neutrophil-mediated mucosal inflammation in inflammatory bowel diseases.转位蛋白促进炎症性肠病中中性粒细胞介导的黏膜炎症。
World J Gastroenterol. 2025 Jul 21;31(27):109239. doi: 10.3748/wjg.v31.i27.109239.
2
Serum regenerative islet-derived protein 1α: a novel and sensitive biomarker for endoscopic disease activity in ulcerative colitis.血清再生胰岛衍生蛋白1α：溃疡性结肠炎内镜下疾病活动的一种新型敏感生物标志物。
Ann Med. 2025 Dec;57(1):2496404. doi: 10.1080/07853890.2025.2496404. Epub 2025 Apr 28.
3
Perspectives in clinical research on Azathioprine for steroid-dependent ulcerative colitis.
硫唑嘌呤治疗激素依赖型溃疡性结肠炎的临床研究视角
Front Med (Lausanne). 2025 Mar 25;12:1551906. doi: 10.3389/fmed.2025.1551906. eCollection 2025.
4
Complications of invasive oral procedures in patients with immune-mediated inflammatory disorders treated with biological and conventional disease-modifying antirheumatic drugs or glucocorticoids: a scoping review of the literature.接受生物制剂和传统改善病情抗风湿药物或糖皮质激素治疗的免疫介导性炎症疾病患者侵入性口腔治疗的并发症：文献综述
BMC Oral Health. 2025 Mar 27;25(1):442. doi: 10.1186/s12903-024-05414-z.
5
Microbiota-derived IPA alleviates intestinal mucosal inflammation through upregulating Th1/Th17 cell apoptosis in inflammatory bowel disease.微生物群衍生的吲哚丙酸通过上调炎症性肠病中Th1/Th17细胞凋亡来减轻肠道黏膜炎症。
Gut Microbes. 2025 Dec;17(1):2467235. doi: 10.1080/19490976.2025.2467235. Epub 2025 Feb 16.
6
Redox-Induced Stabilization of AMBRA1 by USP7 Promotes Intestinal Oxidative Stress and Colitis Through Antagonizing DUB3-Mediated NRF2 Deubiquitination.USP7介导的AMBRA1氧化还原诱导稳定通过拮抗DUB3介导的NRF2去泛素化促进肠道氧化应激和结肠炎。
Adv Sci (Weinh). 2025 Mar;12(12):e2411320. doi: 10.1002/advs.202411320. Epub 2025 Jan 31.
7
Controversies in the management of anti-TNF therapy in patients with Crohn's disease: a Delphi consensus.抗 TNF 治疗克罗恩病患者管理中的争议：德尔菲共识。
BMJ Open Gastroenterol. 2024 Jan 23;11(1):e001246. doi: 10.1136/bmjgast-2023-001246.
8
Knowledge, attitude, and practice of patients living with inflammatory bowel disease: A cross-sectional study.炎症性肠病患者的知识、态度和实践：一项横断面研究。
World J Gastroenterol. 2023 Nov 21;29(43):5818-5833. doi: 10.3748/wjg.v29.i43.5818.
9
Complementary and alternative medicine mention and recommendations in inflammatory bowel disease guidelines: systematic review and assessment using AGREE II.补充和替代医学在炎症性肠病指南中的提及和建议：使用 AGREE II 进行系统评价和评估。
BMC Complement Med Ther. 2023 Jul 11;23(1):230. doi: 10.1186/s12906-023-04062-0.
10
Chitosan functionalized MnO nanoparticles counteracts ulcerative colitis in mice through modulation of cellular redox state.壳聚糖功能化 MnO 纳米颗粒通过调节细胞氧化还原状态来对抗小鼠溃疡性结肠炎。
Commun Biol. 2023 Jun 16;6(1):647. doi: 10.1038/s42003-023-05023-6.